Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/1992
12/15/1992US5171576 Prevention of contact allergy by coadministration of a corticosteroid with a sensitizing drug
12/15/1992US5171566 Flurbiprofen derivative ophthalmic preparation
12/15/1992US5170805 Method of destroying tissue such as a gall bladder utilizing a sclerosing agent alone or with a symphysis agent
12/15/1992US5170567 Electronic inclinometer
12/15/1992CA2102619A1 Transformed erythrocytes, process for preparing the same, and their use in pharmaceutical compositions
12/15/1992CA2071181A1 Benzodiazepine analogs
12/15/1992CA2071143A1 Squalene synthetase inhibitors and processes therefrom
12/15/1992CA2071092A1 1,4-benzodiazepines with 5-membered heterocyclic rings
12/15/1992CA2070243A1 Chroman derivatives
12/15/1992CA1311501C Calciferol derivatives
12/15/1992CA1311487C Derivatives of 1-benzyl-2-oxo-5-alcoxypyrrolidine, a process for their preparation and compositions containing them
12/15/1992CA1311486C Substituted 2,3,4,9-tetrahydro-1h-carbazole-1-acetic acid
12/15/1992CA1311485C Substituted 2,3,4-9-tetrahydro-1h-carbazole-1-acetic acid
12/15/1992CA1311484C Substituted 2,3,4,9-tetrahydro-1h-carbazole-1-acetic acid
12/15/1992CA1311483C 5-pyrazolylcarbonyl- and 5-pyrazolyvinyl-phenoxy acetic acid derivatives and processes for preparing the same
12/15/1992CA1311481C 1,4-dihydropyridines, to their obtention processes and to their use asantithrombotic drugs
12/15/1992CA1311479C Derivatives of quinuclidine spiro (1,3-oxathiolane-5,3-) quinuclidine compounds
12/15/1992CA1311477C 1-hydroxy-5-oxo-5h-pyrido¬3,2-a|phenoxazine -3-carboxylic acid esters
12/15/1992CA1311475C Process for preparing partial polyol fatty acid esters
12/15/1992CA1311474C Process for preparing polyol fatty acid polyesters
12/15/1992CA1311472C 3'-demethoxyepipodophyllotoxin glucoside derivatives
12/15/1992CA1311434C2 Antitumor agent and method for treating tumor using the same
12/15/1992CA1311420C Interstitial administration of perfluorochemical emulsions for reoxygenation of hypoxic tumor cells
12/15/1992CA1311419C Utilization of otilonium bromide for topical application in the gastrointestinal tract and pharmaceutical formulations appropriate for such use
12/15/1992CA1311418C Eyedrops
12/15/1992CA1311417C Antidiabetic composition comprising 7-thiaprostaglandin e _or its derivative
12/15/1992CA1311416C Composition comprising an oxygenated cholesterol and use thereof for topical treatment of diseases
12/15/1992CA1311387C Preservative composition and method
12/14/1992CA2071094A1 Inhibiting agent against the proliferation of malignant tumor cells of animals including human beings and its manufacture
12/14/1992CA2070953A1 Thiopyrano (2,3,4-c,d) indoles as inhibitors of leukotriene biosynthesis
12/13/1992CA2070895A1 7-oxabicycloheptyl substituted heterocyclic amide prostaglandin analogs useful in the treatment of thrombotic and vasospastic disease
12/12/1992CA2070983A1 Cyclic renin inhibitors
12/12/1992CA2070978A1 Cyclic renin inhibitors
12/12/1992CA2070972A1 Cyclic renin inhibitors
12/12/1992CA2070960A1 Cycloalk-3-ene-1,5-diyne derivatives; process for preparing the same and pharmaceutical compositions containing them
12/12/1992CA2070796A1 Arylethers, their manufacture and methods of treatment
12/12/1992CA2070795A1 Amidino compounds, their manufacture and methods of treatment
12/11/1992WO1992022299A2 Use of antiarrhythmic agents to lower cholesterol
12/11/1992CA2089164A1 Use of antiarrhythmic agents to lower cholesterol
12/11/1992CA2070548A1 Bathing preparation
12/11/1992CA2044211A1 Etoposide analogues
12/10/1992WO1992021750A1 Eukaryotic expression vectors with regulation of rna processing
12/10/1992WO1992021696A1 Hydroxyazido derivatives and related compounds as renin inhibitors
12/10/1992WO1992021695A1 Vitamin d derivatives comprising a lateral chain expoxide group
12/10/1992WO1992021692A1 Oligo-2'-deoxynucleotides and their use as drugs with an antiviral action
12/10/1992WO1992021691A1 2',5'-nucleotide analogs as antiviral agents
12/10/1992WO1992021683A1 New cephem compounds
12/10/1992WO1992021680A1 Aza-6-indole-derived compounds as benzodiazepine receptor ligands and drugs containing same
12/10/1992WO1992021676A1 Crystalline oxathiolane derivatives
12/10/1992WO1992021670A1 New biotenside ester and phosphatide with vitamin d and vitamin e compounds; their preparation and transformation into spontaneously dispersible concentrates and their use for treating tumors
12/10/1992WO1992021669A1 2-phenylbenzo[b]furans and thiophenes, methods of preparing them and pharmaceutical preparations containing them
12/10/1992WO1992021663A1 Benzimidazole-derived compounds, method for preparing same, and therapeutical and cosmetic uses thereof
12/10/1992WO1992021659A1 Pyridonecarboxylic acid derivative
12/10/1992WO1992021654A2 Carboxamido-(3,2n)-carbocyclic-2-aminotetralin derivatives
12/10/1992WO1992021648A1 Amino acid derivative anticonvulsant
12/10/1992WO1992021647A1 Carbocyclic and heterocyclic hiv protease inhibitors
12/10/1992WO1992021643A1 Azulenic retinoid compounds, compositions and methods
12/10/1992WO1992021365A1 Therapeutic compositions for osteoinduction
12/10/1992WO1992021355A1 Calcium, trace mineral, vitamin d and drug therapy combinations
12/10/1992WO1992021354A1 Methods and compositions based on inhibition of cell invasion and fibrosis by anionic polymers
12/10/1992WO1992021353A1 Compositions and delivery systems for transdermal administration of neutral oligomers
12/10/1992WO1992021350A1 Combination of nsaids and prostaglandins and uses therefor
12/10/1992WO1992021349A1 Combinations of alpha-2 adrenergic agonists with alpha-3 antagonists for lowering intraocular pressure
12/10/1992WO1992021348A1 Pharmaceutical formulations of a benzodiazepine
12/10/1992WO1992021347A1 Improved euthanasia compositions
12/10/1992WO1992021346A1 Linsidomin for treating erectile dysfunctions
12/10/1992WO1992021344A2 Modulation of cellular response to external stimuli
12/10/1992WO1992021342A1 Antidiabetic
12/10/1992WO1992021340A1 A method of treating infectious encephalitis of viral or bacterial, or parasitic pathogenesis
12/10/1992WO1992021339A1 Isoxazole and isothiazole compounds that enhance cognitive function
12/10/1992WO1992021338A1 Medetomidine preparations for transdermal administration
12/10/1992WO1992021337A1 Methods of treating injury to the central nervous system
12/10/1992WO1992021336A1 Cholesterol-lowering tocopherol analogs
12/10/1992WO1992021335A1 Phospholipids
12/10/1992WO1992021334A1 Pharmaceutical compositions containing 4-substituted imidazoles to be administered transdermally
12/10/1992WO1992021333A2 Treatment of drug withdrawal symptoms and drug craving with type b monoamine oxidase inhibitors
12/10/1992WO1992021329A1 Biodegradable particulate vector and method of synthesis
12/10/1992WO1992021327A1 Microspheres useful for therapeutic vascular occlusions and injectable solutions containing the same
12/10/1992WO1992021324A1 Pharmaceutical enema preparation
12/10/1992WO1992021323A1 Use of lysophosphate acids for the treatment of skin wrinkles
12/10/1992WO1992021321A1 Method for separating a vegetable compound
12/10/1992WO1992021317A1 Pyridine 1-oxide based composition for combatting hair loss and for inducing and stimulating hair growth
12/10/1992WO1992021242A1 Insecticide composition
12/10/1992WO1992021239A1 Blended carboxylic acid sanitizer
12/10/1992WO1992019617A3 Substituted dibenzoxazepine compounds, pharmaceutical compositions and methods of use
12/10/1992WO1992019244A3 A method for treating infectious respiratory diseases
12/10/1992WO1992018111A3 Pharmaceutical composition for the treatment of gastritis
12/10/1992WO1992018092A3 1-arylheteroarylalkyl substituted-1h-1,2,4-triazole compounds for treatment of circulatory disorders
12/10/1992WO1992018090A3 Antimicrobial oral compositions
12/10/1992WO1992017445A3 S-nitrosothiols as smooth muscle relaxants and therapeutic uses thereof
12/10/1992WO1992017184A3 Bioactive topical siloxane compositions having enhanced performance and safety
12/10/1992WO1992017064A3 Inhibitors of protein kinase C function
12/10/1992WO1992017025A3 GnRH analogs
12/10/1992WO1992004359A3 Monosaccharides having anti-proliferation and anti-inflammatory activity, compositions and uses thereof
12/10/1992DE4118741A1 Neue hetaryloxy-(beta)-carboline, deren herstellung und verwendung in arzneimitteln New hetaryloxy (beta) carbolines, their production and use in pharmaceutical preparations
12/10/1992DE4118550A1 Animal pharmaceutical for control of pigeon populations - comprises non-resorbable carrier in which substance inhibiting reproduction is uniformly distributed
12/10/1992CA2110381A1 Hydroxyazido derivatives and related compounds as renin inhibitors
12/10/1992CA2110299A1 Compounds derives from aza-6-indoles, benzodiazepine receptor ligands and drugs containing same
12/10/1992CA2110275A1 Linsidomin for treating erectile dysfunctions
12/10/1992CA2110158A1 Vitamin d derivatives comprising a lateral chain expoxide group
1 ... 7227 7228 7229 7230 7231 7232 7233 7234 7235 7236 7237 7238 7239 7240 7241 7242 7243 7244 7245 7246 7247 ... 7860